For Patients
The Covid Medicines Delivery Unit (CMDU) provides assessment and Covid antiviral treatment for patients who are in the ‘highest risk’ group of clinical vulnerability.
If you believe you are in this group. For referral contacts either your own GP surgery or 111
Please note as most people are now well protected by vaccination the ‘highest risk’ group is limited to patients who have a condition which significantly lowers their immunity or who are on medication or treatments that do this.
For more information, please email blmkicb.cmdu@nhs.net
For Clinicians
Antiviral medicines for the treatment of non-hospitalised patients with coronavirus (COVID-19) infection are available via the COVID medicines delivery unit (CMDU) in BLMK where the following criteria are met:
- patient falls within the ‘highest risk’ group as defined in the national clinical policy (see below)
- patient is symptomatic, showing no signs of clinical improvement and their symptom onset is predominantly within 5 days
- patient has COVID-19 infection confirmed with a positive lateral flow test
These treatments are accessible through the CMDU multidisciplinary clinical triage team, who receive completed referral forms, assess and prescribe, if clinically indicated and in line with the NICE clinical guidelines.
- COVID-19 rapid guideline: Managing COVID-19 – Refer to Section 4 – Therapeutics
- Higher-risk patients eligible for COVID-19 treatments (March 2023)
